Literature DB >> 20502476

Reliability of fasting plasma alkylresorcinol concentrations measured 4 months apart.

J Montonen1, R Landberg, A Kamal-Eldin, P Aman, S Knueppel, H Boeing, T Pischon.   

Abstract

BACKGROUND/
OBJECTIVES: Alkylresorcinols (ARs) have been suggested as specific dietary biomarkers of whole-grain intake. Evaluation of long-term reliability in repeatedly collected samples in population-based studies is needed to assess whether plasma AR reflect long-term exposure and may be used to study exposure-disease relationships in large-scale epidemiologic studies. The objective of this study was to analyze the reliability (reproducibility) of AR concentrations in fasting plasma measured 4 months apart. SUBJECTS/
METHODS: AR concentrations (C17:0, C19:0, C21:0, C23:0 and C25:0 and total ARs) were measured in fasting plasma samples from 100 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study with an interval of 4 months between blood sampling.
RESULTS: Fasting plasma AR concentrations were not significantly different between the first and second measurement over the 4-month period. Geometric means of total AR concentrations were 48.8 (95% confidence interval (CI)=41.5-57.3) nmol/l at the first and 48.7 (95% CI=41.4-57.4) nmol/l at the second measurement (P=0.99). The intraclass correlation coefficients for total AR concentrations were 0.42 (95% CI=0.25-0.57) for all, 0.55 (95% CI=0.32-0.72) for women, and 0.17 (95% CI=-0.11-0.42) for men. Comparable results were obtained for the individual homologues.
CONCLUSIONS: Overall, we observed moderate reliability in concentration of total AR and individual homologues over time, although reliability was weaker in men than in women. These findings should be taken into account when using AR as blood biomarkers for whole-grain intake in large-scale epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502476     DOI: 10.1038/ejcn.2010.71

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  8 in total

1.  Comparison of plasma alkylresorcinols (AR) and urinary AR metabolites as biomarkers of compliance in a short-term, whole-grain intervention study.

Authors:  Nicola M McKeown; Matti Marklund; Jiantao Ma; Alastair B Ross; Alice H Lichtenstein; Kara A Livingston; Paul F Jacques; Helen M Rasmussen; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  Eur J Nutr       Date:  2015-06-05       Impact factor: 5.614

2.  Alkylresorcinol metabolite concentrations in spot urine samples correlated with whole grain and cereal fiber intake but showed low to modest reproducibility over one to three years in U.S. women.

Authors:  Rikard Landberg; Mary K Townsend; Nithya Neelakantan; Qi Sun; Laura Sampson; Donna Spiegelman; Rob M van Dam
Journal:  J Nutr       Date:  2012-03-21       Impact factor: 4.798

3.  Plasma alkylresorcinols as a biomarker of whole-grain food consumption in a large population: results from the WHOLEheart Intervention Study.

Authors:  Alastair B Ross; Alexandre Bourgeois; Harrison Ndung'u Macharia; Sunil Kochhar; Susan A Jebb; Iain A Brownlee; Chris J Seal
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

4.  Plasma alkylresorcinols C17:0/C21:0 ratio, a biomarker of relative whole-grain rye intake, is associated to insulin sensitivity: a randomized study.

Authors:  O K Magnusdottir; R Landberg; I Gunnarsdottir; L Cloetens; B Akesson; M Landin-Olsson; F Rosqvist; D Iggman; U Schwab; K-H Herzig; M J Savolainen; L Brader; K Hermansen; M Kolehmainen; K Poutanen; M Uusitupa; I Thorsdottir; U Risérus
Journal:  Eur J Clin Nutr       Date:  2014-02-19       Impact factor: 4.016

5.  Plasma alkylresorcinols, biomarkers of whole-grain intake, are related to lower BMI in older adults.

Authors:  Jiantao Ma; Alastair B Ross; M Kyla Shea; Stephen J Bruce; Paul F Jacques; Edward Saltzman; Alice H Lichtenstein; Sarah L Booth; Nicola M McKeown
Journal:  J Nutr       Date:  2012-09-05       Impact factor: 4.798

6.  Present status and perspectives on the use of alkylresorcinols as biomarkers of wholegrain wheat and rye intake.

Authors:  Alastair B Ross
Journal:  J Nutr Metab       Date:  2012-01-18

7.  Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer.

Authors:  Cecilie Kyrø; Anja Olsen; Rikard Landberg; Guri Skeie; Steffen Loft; Per Åman; Max Leenders; Vincent K Dik; Peter D Siersema; Tobias Pischon; Jane Christensen; Kim Overvad; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Vanessa Cottet; Tilman Kühn; Jenny Chang-Claude; Heiner Boeing; Antonia Trichopoulou; Christina Bamia; Dimitrios Trichopoulos; Domenico Palli; Vittorio Krogh; Rosario Tumino; Paolo Vineis; Salvatore Panico; Petra H Peeters; Elisabete Weiderpass; Toril Bakken; Lene Angell Åsli; Marcial Argüelles; Paula Jakszyn; María-José Sánchez; Pilar Amiano; José María Huerta; Aurelio Barricarte; Ingrid Ljuslinder; Richard Palmqvist; Kay-Tee Khaw; Nick Wareham; Timothy J Key; Ruth C Travis; Pietro Ferrari; Heinz Freisling; Mazda Jenab; Marc J Gunter; Neil Murphy; Eilo Riboli; Anne Tjønneland; H B as Bueno-de-Mesquita
Journal:  J Natl Cancer Inst       Date:  2013-12-07       Impact factor: 13.506

8.  Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome--a randomized study.

Authors:  Ola Kally Magnusdottir; Rikard Landberg; Ingibjorg Gunnarsdottir; Lieselotte Cloetens; Björn Åkesson; Fredrik Rosqvist; Ursula Schwab; Karl-Heinz Herzig; Janne Hukkanen; Markku J Savolainen; Lea Brader; Kjeld Hermansen; Marjukka Kolehmainen; Kaisa Poutanen; Matti Uusitupa; Ulf Risérus; Inga Thorsdottir
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.